Fielder Capital Group LLC Grows Position in Doximity, Inc. (NASDAQ:DOCS)

Fielder Capital Group LLC raised its position in shares of Doximity, Inc. (NASDAQ:DOCS) by 4.5% during the 4th quarter, Holdings Channel reports. The fund owned 5,488 shares of the company’s stock after purchasing an additional 235 shares during the period. Fielder Capital Group LLC’s holdings in Doximity were worth $293,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently modified their holdings of DOCS. Handelsbanken Fonder AB increased its stake in Doximity by 0.7% during the fourth quarter. Handelsbanken Fonder AB now owns 29,700 shares of the company’s stock worth $1,586,000 after acquiring an additional 200 shares during the last quarter. UMB Bank n.a. increased its position in shares of Doximity by 69.1% during the 4th quarter. UMB Bank n.a. now owns 575 shares of the company’s stock valued at $31,000 after purchasing an additional 235 shares during the last quarter. GAMMA Investing LLC increased its position in shares of Doximity by 20.6% during the 4th quarter. GAMMA Investing LLC now owns 1,735 shares of the company’s stock valued at $93,000 after purchasing an additional 296 shares during the last quarter. MetLife Investment Management LLC raised its holdings in Doximity by 0.6% during the 3rd quarter. MetLife Investment Management LLC now owns 65,064 shares of the company’s stock valued at $2,835,000 after buying an additional 363 shares during the period. Finally, State of Alaska Department of Revenue lifted its position in Doximity by 2.6% in the fourth quarter. State of Alaska Department of Revenue now owns 14,610 shares of the company’s stock worth $780,000 after buying an additional 370 shares during the last quarter. 87.19% of the stock is currently owned by institutional investors.

Doximity Stock Down 4.6 %

Shares of NASDAQ:DOCS opened at $69.54 on Friday. The firm has a 50 day moving average of $61.66 and a 200 day moving average of $50.26. The company has a market capitalization of $12.98 billion, a price-to-earnings ratio of 69.54, a price-to-earnings-growth ratio of 4.10 and a beta of 1.39. Doximity, Inc. has a 52 week low of $22.96 and a 52 week high of $85.21.

Insider Buying and Selling

In other Doximity news, Director Timothy S. Cabral sold 20,000 shares of the business’s stock in a transaction dated Monday, February 3rd. The shares were sold at an average price of $57.62, for a total value of $1,152,400.00. Following the completion of the transaction, the director now directly owns 6,360 shares in the company, valued at approximately $366,463.20. The trade was a 75.87 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 37.40% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

A number of research analysts have weighed in on DOCS shares. Stephens assumed coverage on shares of Doximity in a research report on Friday, December 20th. They set an “equal weight” rating and a $55.00 price objective on the stock. Leerink Partnrs upgraded shares of Doximity from a “hold” rating to a “strong-buy” rating in a report on Friday, February 7th. Canaccord Genuity Group downgraded shares of Doximity from a “buy” rating to a “hold” rating and raised their price objective for the stock from $40.00 to $60.00 in a research note on Wednesday, November 13th. JPMorgan Chase & Co. boosted their target price on Doximity from $30.00 to $48.00 and gave the company a “neutral” rating in a research report on Thursday, November 21st. Finally, Mizuho increased their price target on Doximity from $55.00 to $65.00 and gave the stock a “neutral” rating in a report on Monday, February 10th. Eleven investment analysts have rated the stock with a hold rating, eight have issued a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $64.22.

Doximity Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.